SERA
Sera Prognostics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.02
+2.02%Margins
Gross margin
-150.0%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-56.0%
Return on equity
-38.3%
Return on assets
-59.8%
Return on invested capital
0.00x
Asset turnover
-$27.7M
Cash from operations
$1.18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026